Patient info Open main menu

Regurin XL 60 mg prolonged-release capsule hard – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
60 mg
Other strengths and forms:
Contains active substance:
ATC code:

Patient leaflet - Regurin XL 60 mg prolonged-release capsule hard

1. What Regurin XL is and what it is used for

  1. 2. What do you need to know before you take Regurin XL
  2. 3. How to take Regurin XL
  3. 4. Possible side effects
  4. 5. How to store Regurin XL
  5. 6.
    1. 1. WHAT REGURIN XL IS AND WHAT IT IS USED FOR

Regurin XL is a medicine used for the relaxation of the muscles of the muscles of the urinary bladder. It is used for the treatment of symptoms associated with involuntary loss of urine (wetting) and/or increased frequency of urination and/ or urgency of urination in patients with an overactive bladder.

2. WHAT DO YOU NEED TO KNOW BEFORE YOU TAKE REGURIN XL

Do not take Regurin XL

  • If you have ever had an allergic reaction to trospium chloride or any of the other ingredients of this medicine (listed in section 6). (An allergic reaction can be a rash, itchiness or shortness of breath.).
  • If you suffer from any of the following:
  • urinary retention, i.e. blockage of the urinary tract,
  • the eye condition narrow-angle glaucoma,
  • abnormal/faster than normal heart beats,
  • myasthenia gravis (a disorder that causes muscle fatigue),
  • a severe gastro-intestinal condition, such as toxic megacolon,
  • problems with your kidneys,
  • severe problems with your liver.

Warnings and precautions

Talk to your doctor of pharmacist before taking Regurin XL if you suffer from any of the following:

  • any type of stomach or bowel obstruction,
  • an impaired urine flow (e.g. in the case of benign tissue growth of the male prostate),
  • neuropathy, i.e. nerve damage,
  • a hiatus hernia associated with reflux oesophagitis. This is usually associated with heartburn which worsens on bending or lying down
  • an overactive thyroid,
  • any heart conditions, such as coronary artery disease or congestive heart failure,
  • any liver problems.

Patients with liver disorders

You should talk to your doctor if you have a liver disorder. Patients with severe liver disorders should not take this medicine.

Patients with kidney disorders

You should talk to your doctor if you have a kidney disorder.

Patients with kidney disorders should not take this medicine.

Children under the age of 18 years

Do NOT give Regurin XL to children under 18 years of age.

Other medicines and Regurin XL

Please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.

Inform your doctor in particular if you are taking any of the following medicines:

  • certain antidepressants e.g. amitryptiline or imipramine
  • some medicines for the treatment of asthma that may accelerate the heart rate (e.g. salbutamol)
  • other medicines with anticholinergic action (e.g. amantadine - used to treat Parkinson’s disease)
  • metoclopramide – medicine used for nausea and vomiting
  • medicines containing guar, colestipol or colestyramine.

Please note that this information may also apply to medicines that you have used recently.

Pregnancy and breast-feeding and fertility

Since there is no experience with trospium chloride during pregnancy and breast feeding, Regurin XL should be taken during pregnancy and breast-feeding only if your doctor considers it absolutely necessary.

Driving and using machines

Even when used as directed, this medicine can affect vision so that the ability to actively participate in road traffic, operate machines or work may be impaired. Therefore, do not drive motor vehicles, operate machines or perform other hazardous activities if you are suffering from blurred vision.

Regurin XL contains sucrose and sodium

If you have been told by your doctor that you have an intolerance to some sugars, such as sucrose, contact your doctor before taking this medicine.

This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say it is essentially ‘sodium-free’

3. HOW TO TAKE REGURIN XL

Always take Regurin XL exactly as your doctor has told you.

Check with your doctor or pharmacist if you are not sure.

Usual dose unless otherwise prescribed by your doctor

Unless otherwise prescribed by your doctor, the usual daily dose is one Regurin XL prolonged-release capsule.

Method of administration

Swallow one prolonged-release capsule whole with a glass of water.

Take the capsule at least one hour before meal on an empty stomach.

Duration of administration

Your doctor will determine the duration of treatment. The need for continued treatment should be checked at regular intervals of 3 – 6 months.

Patients with a kidney disorder should consult their doctor and not take this medicine.

Patients with a liver disorder should consult their doctor before taking this medicine.

If you take more Regurin XL than you should

No symptoms and signs of intoxication in humans have been reported to date. If you have taken too much Regurin XL you should inform immediately a doctor or pharmacist who will decide on further measures.

If you forget to take Regurin XL

Do not take a double dose to make up for a forgotten dose. Continue with the regular intake as described in the dosage directions.

If you stop taking Regurin XL

Your symptoms may return if you stop taking Regurin XL before recommended by your doctor. Therefore, you should take Regurin XL for as long as prescribed by your doctor. Please consult your doctor if you wish to stop treatment.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Regurin XL can cause side effects, although not everybody gets them.

The following side effects have been reported for Regurin XL

prolonged-release capsules, hard in clinical trials:

Very common side effects, affects more than 1 user in 10

  • dryness of the mouth.

Common side effects, affects 1 to 10 users in 100

  • constipation, nausea, abdominal pain, indigestion,
  • dry eyes, dry nose.

Uncommon side effects, affects 1 to 10 users in 1,000

  • flatulence

Rare side effects, affects 1 to 10 users in 10,000

  • difficulty emptying the bladder, urinary retention,
  • fast heart rate, palpitations,
  • difficulty seeing objects close-up,
  • rash,
  • general feeling of weakness.

Very rare side effects, affects less than 1 user in 10,000

  • urinary tract infection,
  • headache.

Other possible side effects, for which the frequency is not known:

  • sporadic cases of hallucination, confusion and agitation have

occurred mostly in elderly patients and can be facilitated by neurological diseases and/or other drugs, with a similar mechanism

of action taken at the same time.

The following side effects have also been reported for trospium (trospium is the active ingredient of Regurin XL; it is not known if these side effects will also occur with the capsules that you have been prescribed):

Difficulty in breathing, diarrhoea, chest pain, slight to moderate increase of certain liver values (serum transaminases), fast irregular heartbeat, joint or muscle pains, dizziness.

The following “very rare” side effects below are important and will require immediate action if you experience them. You should stop

taking Regurin XL and see your doctor immediately if the following symptoms occur:

  • swelling of the face, tongue and windpipe which can cause great difficulty in breathing
  • a sudden allergic reaction with shortness of breath, rash, wheezing and drop of blood pressure.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard). By reporting side effects you can help provide more information on the safety of this medicine

5. HOW TO STORE REGURIN XL

Keep this medicine out of the sight and reach of children.

Do not use Regurin XL after the expiry date which is stated

on the blister and the container after EXP.

The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not use Regurin XL if you notice that the package has been damaged or shows signs of tampering.

Medicines should not be disposed of via wastewater or household waste.

Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

If your medicine becomes discoloured or shows any signs of deterioration consult your pharmacist who will advise you what to do.

6. CONTENT OF PACK AND OTHER INFORMATION

What Regurin XL contains

The active substance is: Trospium chloride.

Each prolonged release capsule contains 60 mg trospium chloride.

The other ingredients are:

Capsule contents: Sucrose, Maize starch, Methyl acrylate-methyl methacrylate-methacrylic acid-copolymer, Sodium dodecylsulphate, Ammonium hydroxide, Medium chain triglycerides, Oleic acid, Ethylcellulose, Titanium dioxide (E 171), Hypromellose, Macrogol 400, Polysorbate 80, Triethyl citrate, Talc.

Capsule shell: Gelatin, Titanium dioxide (E 171), Yellow iron oxide (E172), Red iron oxide (E 172), Printing ink (Shellac glaze, Black iron oxide (E 172), Propylene glycol) See section 2 ‘Regurin XL contains sucrose and sodium.

What Regurin XL looks like and contents of the pack

Regurin XL Capsules have an orange opaque cap, and an opaque white body imprinted with 'SAN 60' and contains white to off white pellets.

Regurin XL is available in packs containing 30 or 100 prolonged-release capsules.

Manufacturer

Regurin XL Capsules are manufactured by MADAUS GmbH, 53842 Troisdorf, Germany. Procured from within the EU and repackaged in the UK by the Parallel Import Product Licence holder:

CD Pharma Ltd, 4 Cairn Court, East Kilbride, G74 4NB.

REGURIN XL 60mg PROLONGED RELEASE CAPSULES

PL 20492/0733

Regurin is a trademark of MADAUS GmbH.

Date of preparation: 30th May 2025

Blind or partially sighted? Is this leaflet hard to see or read? Call 01355 204 448 to obtain a leaflet in a format suitable for you.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 20492/0733

Last revision stated in the text: 30 May 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Regurin XL 60 mg prolonged-release capsule hard

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Trospium
Strength 60 mg
Pharmaceutical form Modified-release capsule
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD09 trospium
Marketing authorisation PLPI 20492/0733
Codes BNF 07040200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.